MSK-195, with the CAS number 289902-82-5, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule inhibitor, specifically targeting certain protein interactions that are implicated in various diseases, including cancer. MSK-195 is known for its ability to modulate epigenetic processes, particularly through the inhibition of specific methyltransferases, which play a crucial role in gene expression regulation. The compound exhibits a favorable pharmacokinetic profile, which may include good solubility and permeability, making it a candidate for further development in drug formulation. Additionally, MSK-195 has been studied for its selectivity and potency, which are critical factors in minimizing off-target effects and enhancing therapeutic efficacy. Ongoing research aims to elucidate its mechanism of action and potential applications in clinical settings, particularly in oncology. As with any investigational compound, further studies are necessary to fully understand its safety, efficacy, and potential side effects.

MSK-195

289902-82-5: MSK-195, with the CAS number 289902-82-5, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule inhibitor, specifically targeting certain protein interactions that are implicated in various diseases, including cancer. MSK-195 is known for its ability to modulate epigenetic processes, particularly through the inhibition of specific methyltransferases, which play a crucial role in gene expression regulation. The compound exhibits a favorable pharmacokinetic profile, which may include good solubility and permeability, making it a candidate for further development in drug formulation. Additionally, MSK-195 has been studied for its selectivity and potency, which are critical factors in minimizing off-target effects and enhancing therapeutic efficacy. Ongoing research aims to elucidate its mechanism of action and potential applications in clinical settings, particularly in oncology. As with any investigational compound, further studies are necessary to fully understand its safety, efficacy, and potential side effects.

Propanoic acid, 2,2-dimethyl-, 3-[[2-[4-(2-aminoethoxy)-3-methoxyphenyl]acetyl]amino]-2-[(3,4-dimethylphenyl)methyl]propyl ester

<p>MSK-195 is an effective TRPV1 agonist.</p>

CAS 289902-82-5

MSK-195

Propanoic acid, 2,2-dimethyl-, 3-[[2-[4-(2-aminoethoxy)-3-methoxyphenyl]acetyl]amino]-2-[(3,4-dimethylphenyl)methyl]propyl ester

Ref: IN-DA002V4I

MSK-195

Ref: TM-T24504